BSCL2

BSCL2

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">BSCL2</th>
</tr>
<tr>
<td class="label">gene = BSCL2</td>
<td>name = BSCL2 Lipid Droplet Biogenesis Associated (Seipin) [@wang2015]</td>
</tr>
<tr>
<td class="label">ncbi_gene_id = 27171 [@liu2021]</td>
<td>ensembl = ENSG00000128590 [@berardinelli1954]</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

{{ infobox .infobox-gene
| gene = BSCL2
| name = BSCL2 Lipid Droplet Biogenesis Associated (Seipin) [@wang2015]
| chromosome = 11q13.1 [@klein2017]
| ncbi_gene_id = 27171 [@liu2021]
| ensembl = ENSG00000128590 [@berardinelli1954]
| omim = 604158 [@seip1991]
| uniprot = O95456
| diseases = Hereditary Spastic Paraplegia 17, Berardinelli-Seip Congenital Lipodystrophy Type 2, Congenital Generalized Lipodystrophy
}}

Overview

BSCL2

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">BSCL2</th>
</tr>
<tr>
<td class="label">gene = BSCL2</td>
<td>name = BSCL2 Lipid Droplet Biogenesis Associated (Seipin) [@wang2015]</td>
</tr>
<tr>
<td class="label">ncbi_gene_id = 27171 [@liu2021]</td>
<td>ensembl = ENSG00000128590 [@berardinelli1954]</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

{{ infobox .infobox-gene
| gene = BSCL2
| name = BSCL2 Lipid Droplet Biogenesis Associated (Seipin) [@wang2015]
| chromosome = 11q13.1 [@klein2017]
| ncbi_gene_id = 27171 [@liu2021]
| ensembl = ENSG00000128590 [@berardinelli1954]
| omim = 604158 [@seip1991]
| uniprot = O95456
| diseases = Hereditary Spastic Paraplegia 17, Berardinelli-Seip Congenital Lipodystrophy Type 2, Congenital Generalized Lipodystrophy
}}

Overview

BSCL2 (Berkman-Serpin Clade Homolog 2), also known as Seipin, is a crucial endoplasmic reticulum (ER) protein encoded by the BSCL2 gene on chromosome 11q13.1. This gene encodes a transmembrane protein that plays a fundamental role in lipid droplet biogenesis, ER homeostasis, and neuronal lipid metabolism. BSCL2 mutations are associated with two distinct clinical phenotypes: hereditary spastic paraplegia type 17 (HSP17), a neurodegenerative disorder characterized by progressive lower limb spasticity, and Berardinelli-Seip congenital lipodystrophy type 2 (BSCL2), a rare autosomal recessive disorder marked by severe loss of adipose tissue and metabolic complications.

The seipin protein has garnered significant attention in neurodegeneration research due to its essential role in maintaining neuronal lipid homeostasis, particularly at synaptic terminals where lipid metabolism is critical for neurotransmitter release and membrane recycling.

Function

Lipid Droplet Biogenesis

Seipin is a key regulator of lipid droplet formation in eukaryotic cells. Located in the ER membrane, seipin forms oligomeric complexes that facilitate the nucleation and growth of lipid droplets [1](https://pubmed.ncbi.nlm.nih.gov/20389276/). The protein contains a highly conserved domain that interacts with triglycerides and phospholipids, mediating the proper distribution of lipids between the ER membrane and nascent lipid droplets.

In adipocytes, seipin is essential for:

• Lipid droplet nucleation: Initiating the formation of lipid droplets from ER-localized lipid precursors
• Lipid droplet growth: Facilitating the expansion of lipid droplets through lipid transfer
• Lipid droplet positioning: Ensuring proper subcellular distribution of lipid droplets

Endoplasmic Reticulum Morphology and Homeostasis

Seipin plays a critical role in maintaining ER morphology and function. Studies have shown that BSCL2 knockdown leads to altered ER structure, including dilated ER sheets and disrupted ER-mitochondria contacts [2](https://pubmed.ncbi.nlm.nih.gov/20628059/). The protein interacts with several ER-resident proteins involved in lipid metabolism, including:

• FITM proteins: Fat storage-inducing transmembrane proteins that cooperate with seipin in lipid droplet formation
• ACSL enzymes: Acyl-CoA synthetases involved in fatty acid metabolism
• LD proteins: Lipid droplet-associated proteins that regulate droplet dynamics

Neuronal Function and Lipid Homeostasis

In [neurons](/entities/neurons), seipin is particularly important for maintaining lipid homeostasis at synaptic terminals. The brain is enriched in lipids, with synaptic membranes requiring constant turnover and recycling of phospholipids and cholesterol. Seipin ensures proper lipid composition of synaptic vesicles and presynaptic membranes, which is essential for:

• Synaptic vesicle biogenesis: Proper lipid composition is required for vesicle formation and trafficking
• Neurotransmitter release: Synaptic membrane fluidity and fusion properties depend on lipid composition
• Axonal transport: Lipid droplets serve as energy sources for axonal transport in neurons
• Mitochondrial function: Seipin-mediated lipid metabolism affects mitochondrial dynamics and energy production

Interaction with Neurodegeneration Pathways

Seipin intersects with several key pathways implicated in neurodegenerative diseases:

Disease Associations

Hereditary Spastic Paraplegia 17 (HSP17)

Hereditary Spastic Paraplegia 17 (SPG17) is an autosomal recessive form of hereditary spastic paraplegia caused by BSCL2 mutations. This disorder is characterized by progressive spasticity and weakness of the lower limbs, with variable additional neurological features.

Clinical Features

The core clinical manifestations of HSP17 include:

• Progressive spasticity: Bilateral lower limb spasticity that progresses over decades, leading to gait disturbance and eventual wheelchair dependence in severe cases
• Lower limb weakness: Progressive weakness, particularly affecting distal muscles
• Hyperreflexia: Exaggerated deep tendon reflexes in the lower limbs
• Babinski sign: Pathological plantar extension response
• Spastic gait: Characteristic stiff-legged gait pattern

Additional Neurological Features

Many patients with HSP17 develop additional neurological manifestations:

• Cognitive impairment: Mild to moderate cognitive deficits, ranging from learning difficulties to frank intellectual disability
• Peripheral neuropathy: Sensorimotor neuropathy contributing to weakness and sensory loss
• Urinary urgency: Overactive bladder symptoms due to upper motor neuron involvement
• Pseudobulbar affect: Emotional lability in some patients
• Seizures: Occasional seizure activity reported in case studies

Genetics and Pathogenesis

Over 20 pathogenic BSCL2 mutations have been identified in HSP17 patients, including:

• N88S (founder mutation in many families)
• S90L
• R96X
• Exon deletions

• Protein misfolding and ER retention
• Reduced protein stability
• Impaired oligomerization
• Disrupted lipid droplet targeting

Management

Currently, there is no disease-modifying therapy for HSP17. Management focuses on:

• Physical therapy: Maintaining mobility and preventing contractures
• Antispastic medications: Baclofen, tizanidine, or benzodiazepines
• Orthopedic interventions: Tendon lengthening for contractures
• Assistive devices: Walking aids and wheelchairs as needed
• Regular monitoring: Neurological assessments and imaging to track progression

Berardinelli-Seip Congenital Lipodystrophy Type 2 (BSCL2)

Berardinelli-Seip Congenital Lipodystrophy Type 2 (BSCL2) is a rare autosomal recessive disorder characterized by near-complete loss of adipose tissue from birth, leading to severe metabolic complications.

Clinical Features

• Agenesis of adipose tissue: Near-total absence of subcutaneous fat, with fat accumulating in liver and skeletal muscle
• Muscular appearance: Prominent musculature due to absence of subcutaneous fat
• Acanthosis nigricans: Hyperpigmented, velvety skin in flexural areas
• Hepatosplenomegaly: Enlarged liver and spleen due to fat accumulation

Metabolic Complications

• Severe insulin resistance: Leading to hyperglycemia and type 2 diabetes
• Hypertriglyceridemia: Extremely elevated triglyceride levels
• Hepatic steatosis: Fat accumulation in the liver, progressing to steatohepatitis
• Polycystic ovary syndrome: In female patients

Neurological Manifestations in BSCL2

Recent studies have identified neurological involvement in BSCL2 patients:

• Cognitive impairment: Variable intellectual disability
• Behavioral problems: Autism spectrum features in some patients
• Motor delays: Delayed motor development in childhood
• Peripheral neuropathy: Reported in long-term survivors

Emerging Research: BSCL2 in Alzheimer's and Parkinson's Disease

Recent research suggests potential involvement of BSCL2 in more common neurodegenerative diseases:

• Alzheimer's disease: BSCL2 expression is altered in AD brain tissue, and seipin dysfunction may contribute to lipid raft abnormalities and amyloid processing
• Parkinson's disease: Seipin has been implicated in [alpha-synuclein](/proteins/alpha-synuclein) aggregation and mitochondrial dysfunction in PD models
• Amyotrophic lateral sclerosis: BSCL2 variants may modify disease progression in some ALS patients

Expression

Brain Expression

BSCL2 is widely expressed throughout the brain with notable enrichment in:

• Cerebral [cortex](/brain-regions/cortex): High expression in layer 5 pyramidal neurons
• [Hippocampus](/brain-regions/hippocampus): Particularly in CA1 and CA3 pyramidal cells
• Cerebellum: Purkinje cells show strong expression
• Basal ganglia: Medium spiny neurons in the striatum
• Brainstem: Motor neurons and sensory relay neurons

Peripheral Tissue Expression

• Adipose tissue: Very high expression in subcutaneous and visceral fat
• Liver: High expression in hepatocytes
• Skeletal muscle: Moderate expression
• Heart: Low to moderate expression
• Pancreas: Islet cells show expression

Key Publications

Allen Brain Atlas Resources

BSCL2 expression data available from the Allen Brain Atlas:

• [Human Brain Atlas - BSCL2 Expression](https://human.brain-map.org/microarray/search/show?search_term=BSCL2): Gene expression data across brain regions
• [Allen Cell Type Atlas](https://celltypes.brain-map.org/): Cellular expression patterns in specific neuronal types
• [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/): Developmental expression patterns

Therapeutic Implications

Potential Therapeutic Approaches

• Development of pati
• Hereditary Spastic Paraplegia
• Lipid Metabolism
• Endoplasmic Reticulum Stress
• Berardinelli-Seip Congenital Lipodystrophy
• Motor Neuron Diseases
• Lipid Droplets in Neurodegeneration
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• ER-Mitochondria Contacts

External Links

• [BSCL2 Gene - NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/27171)
• [BSCL2 Protein - UniProt](https://www.uniprot.org/uniprotkb/O95456/entry)
• [OMIM: BSCL2](https://www.omim.org/entry/604158)
• [BSCL2 - Ensembl](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000128590)
• [HGNC: BSCL2](https://www.genenames.org/data/hgnc_complete_set.txt)
• [GeneReviews: Hereditary Spastic Paraplegia Overview](https://www.ncbi.nlm.nih.gov/books/NBK1169/)

References